ANASTASIS BIOTEC LIMITED

ANASTASIS BIOTEC LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameANASTASIS BIOTEC LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 10502511
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of ANASTASIS BIOTEC LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is ANASTASIS BIOTEC LIMITED located?

    Registered Office Address
    56 Haverstock Hill Haverstock Hill
    NW3 2BH London
    United Kingdom
    Undeliverable Registered Office AddressNo

    What are the latest accounts for ANASTASIS BIOTEC LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnDec 31, 2025
    Next Accounts Due OnSep 30, 2026
    Last Accounts
    Last Accounts Made Up ToDec 31, 2024

    What is the status of the latest confirmation statement for ANASTASIS BIOTEC LIMITED?

    Last Confirmation Statement Made Up ToNov 07, 2026
    Next Confirmation Statement DueNov 21, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToNov 07, 2025
    OverdueNo

    What are the latest filings for ANASTASIS BIOTEC LIMITED?

    Filings
    DateDescriptionDocumentType

    Statement of capital following an allotment of shares on Oct 29, 2025

    • Capital: GBP 35,173.94
    4 pagesSH01

    Total exemption full accounts made up to Dec 31, 2024

    7 pagesAA

    Confirmation statement made on Nov 07, 2025 with updates

    12 pagesCS01

    Statement of capital following an allotment of shares on Sep 01, 2025

    • Capital: GBP 35,162.43
    3 pagesSH01

    Termination of appointment of Mahendra Persaud Deonarain as a director on May 22, 2025

    1 pagesTM01

    Statement of capital following an allotment of shares on May 06, 2025

    • Capital: GBP 33,465.63
    5 pagesSH01

    Statement of capital following an allotment of shares on Feb 25, 2025

    • Capital: GBP 33,442.77
    6 pagesSH01

    Confirmation statement made on Nov 07, 2024 with updates

    10 pagesCS01

    Amended total exemption full accounts made up to Dec 31, 2023

    9 pagesAAMD

    Accounts for a dormant company made up to Dec 31, 2023

    10 pagesAA

    Statement of capital following an allotment of shares on May 28, 2024

    • Capital: GBP 33,357.15
    3 pagesSH01

    Statement of capital following an allotment of shares on Apr 19, 2024

    • Capital: GBP 33,352.53
    3 pagesSH01

    Appointment of Dr Christina Andrea Kousparou as a director on Feb 06, 2024

    2 pagesAP01

    Statement of capital following an allotment of shares on Feb 02, 2024

    • Capital: GBP 33,308.17
    4 pagesSH01

    Statement of capital following an allotment of shares on Oct 31, 2023

    • Capital: GBP 33,283.06
    5 pagesSH01

    Confirmation statement made on Nov 07, 2023 with updates

    8 pagesCS01

    Statement of capital following an allotment of shares on Sep 12, 2023

    • Capital: GBP 33,170.56
    4 pagesSH01

    Statement of capital following an allotment of shares on Sep 12, 2023

    • Capital: GBP 33,170.56
    3 pagesSH01

    Statement of capital following an allotment of shares on Sep 07, 2023

    • Capital: GBP 33,155.88
    3 pagesSH01

    Statement of capital following an allotment of shares on Sep 26, 2023

    • Capital: GBP 33,227.47
    4 pagesSH01

    Statement of capital following an allotment of shares on Sep 12, 2023

    • Capital: GBP 33,170.56
    3 pagesSH01

    Statement of capital following an allotment of shares on Sep 14, 2023

    • Capital: GBP 33,171.33
    3 pagesSH01

    Total exemption full accounts made up to Dec 31, 2022

    13 pagesAA

    Statement of capital following an allotment of shares on Sep 05, 2023

    • Capital: GBP 33,125.12
    7 pagesSH01

    Termination of appointment of Laurence John Cohen as a director on Apr 06, 2023

    1 pagesTM01

    Who are the officers of ANASTASIS BIOTEC LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    EPENETOS, Agamemnon Antoniou, Dr
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    United KingdomBritish12213580001
    KOUSPAROU, Christina Andrea, Dr
    Haverstock Hill
    NW3 2BH London
    56a
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56a
    United Kingdom
    CyprusCypriot320577260001
    BRANTHWAITE, Paul
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    EnglandBritish294659260001
    COHEN, Laurence John
    The Avenue
    WD7 7DQ Radlett
    Birchwood
    Hertfordshire
    Uk
    Director
    The Avenue
    WD7 7DQ Radlett
    Birchwood
    Hertfordshire
    Uk
    United KingdomBritish195986490001
    DEONARAIN, Mahendra Persaud, Dr
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    EnglandBritish107822590001
    HUDSON, Alexandra Anna Obolensky, Dr.
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    EnglandBritish258510380001
    KYRIAKIDES, Michael, Mr.
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Director
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    EnglandBritish242312600001

    Who are the persons with significant control of ANASTASIS BIOTEC LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Dr Agamemnon Antoniou Epenetos
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    Nov 29, 2016
    Haverstock Hill
    NW3 2BH London
    56 Haverstock Hill
    United Kingdom
    No
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0